Arcus Biosciences earnings were -$460.0M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest RCUS earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$91.0M, down 28.9% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, RCUS reported annual earnings of -$353.0M, with 24.7% growth. The next RCUS earnings date is Oct 27, 2026.
What were Arcus Biosciences's earnings last quarter?
On RCUS's earnings call on Aug 5, 2026, Arcus Biosciences (NYSE: RCUS) reported Q2 2026 earnings per share (EPS) of -$0.72, up Infinity% year over year. Total RCUS earnings for the quarter were -$91.00 million. In the same quarter last year, Arcus Biosciences's earnings per share (EPS) was $0.00.
The next RCUS earnings call is Oct 27, 2026. Add RCUS to your watchlist to be reminded of Arcus Biosciences's next earnings date.
Is Arcus Biosciences profitable or losing money?
As of the last Arcus Biosciences earnings report, Arcus Biosciences is currently losing money. Arcus Biosciences's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$460.00 million, a 54.36% increase year over year.
What was RCUS's earnings growth in the past year?
As of Arcus Biosciences's earnings date in Aug 5, 2026, Arcus Biosciences's earnings has grown year over year. RCUS earnings in the past year totalled -$460.00 million.
What are Arcus Biosciences's earnings expectations?
The current EPS estimate for Arcus Biosciences's earnings report in Oct 27, 2026 is -$0.95.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.